Literature DB >> 17599310

A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients.

Jessina C McGregor1, Shayna E Rich, Anthony D Harris, Eli N Perencevich, Regina Osih, Thomas P Lodise, Ram R Miller, Jon P Furuno.   

Abstract

Studies of the association between inappropriate antibiotic therapy and mortality among bacteremic patients have generated conflicting findings. We systematically reviewed these studies to identify methodological heterogeneity that may explain the lack of agreement. We identified 51 articles that met the inclusion criteria, and we extracted the following data: study design, definition and measurement of variables, and statistical methods. Only 8 studies (16%) defined inappropriate antibiotic therapy as that which was inactive in vitro against the isolated organism(s) and not consistent with current clinical practice recommendations and distinguished between empiric and definitive treatment. Thirty-four studies (67%) measured the severity of illness, but only 6 (12%) specified the time at which it was measured. The methodological recommendations suggested in this article are intended to improve the validity and generalizability of future research. In brief, future studies should define "inappropriate" therapy on the basis of in vitro susceptibility data, should separately evaluate empiric and definitive therapy, and should control for the baseline severity of illness.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17599310     DOI: 10.1086/519283

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  68 in total

1.  Suitability of initial antibiotic therapy for the treatment of bloodstream infections and the potential role of antibiotic management teams in improving it.

Authors:  S Diamantis; C Rioux; C Bonnal; É Farfour; E Papy; A Andremont; P Yeni; É Bouvet; J-C Lucet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-02       Impact factor: 3.267

2.  Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis.

Authors:  Pilar Retamar; María M Portillo; María Dolores López-Prieto; Fernando Rodríguez-López; Marina de Cueto; María V García; María J Gómez; Alfonso Del Arco; Angel Muñoz; Antonio Sánchez-Porto; Manuel Torres-Tortosa; Andrés Martín-Aspas; Ascensión Arroyo; Carolina García-Figueras; Federico Acosta; Juan E Corzo; Laura León-Ruiz; Trinidad Escobar-Lara; Jesús Rodríguez-Baño
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

Review 3.  Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis.

Authors:  Mical Paul; Vered Shani; Eli Muchtar; Galia Kariv; Eyal Robenshtok; Leonard Leibovici
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

4.  Antibiotic administration longer than eight hours after triage and mortality of community-acquired pneumonia in patients with diabetes mellitus.

Authors:  M S Bader; K A Abouchehade; Y Yi; B Haroon; L D Bishop; J Hawboldt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-02-01       Impact factor: 3.267

5.  Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia.

Authors:  Sung-Han Kim; Kye-Hyung Kim; Hong-Bin Kim; Nam-Joong Kim; Eui-Chong Kim; Myoung-don Oh; Kang-Won Choe
Journal:  Antimicrob Agents Chemother       Date:  2007-11-05       Impact factor: 5.191

6.  Commentary: Back to the future with Sir Bradford Hill: statistical analysis with hospital-acquired infections.

Authors:  Michelle Shardell; Nicholas G Reich; Eli N Perencevich
Journal:  Int J Epidemiol       Date:  2013-09-14       Impact factor: 7.196

7.  Long-term risk for readmission, methicillin-resistant Staphylococcus aureus (MRSA) infection, and death among MRSA-colonized veterans.

Authors:  Nestor M Quezada Joaquin; Daniel J Diekema; Eli N Perencevich; George Bailey; Patricia L Winokur; Marin L Schweizer
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

8.  Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy.

Authors:  Graeme N Forrest; Mary-Claire Roghmann; Latoya S Toombs; Jennifer K Johnson; Elizabeth Weekes; Durry P Lincalis; Richard A Venezia
Journal:  Antimicrob Agents Chemother       Date:  2008-07-28       Impact factor: 5.191

9.  Controlling for severity of illness in outcome studies involving infectious diseases: impact of measurement at different time points.

Authors:  Kerri A Thom; Michelle D Shardell; Regina B Osih; Marin L Schweizer; Jon P Furuno; Eli N Perencevich; Jessina C McGregor; Anthony D Harris
Journal:  Infect Control Hosp Epidemiol       Date:  2008-11       Impact factor: 3.254

10.  Gram-negative bacteraemia in non-ICU patients: factors associated with inadequate antibiotic therapy and impact on outcomes.

Authors:  Jonas Marschall; Denis Agniel; Victoria J Fraser; Joshua Doherty; David K Warren
Journal:  J Antimicrob Chemother       Date:  2008-03-15       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.